Scott Canna
Associate Professor of Pediatrics (Rheumatology) at the Children's Hospital of Philadelphia · University of Pennsylvania Health System
Credentials: · · ·
History
2002–2006
1997–2001
Research
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition
New England Journal of Medicine · 2006 · 686 citations
Case report · Nature Genetics · 2014 · First of 23 authors · 568 citations
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Arthritis & Rheumatology · 2020 · 491 citations
35 papers
27 papers
- RG
21 papers
17 papers
13 papers
- LH
12 papers
11 papers · 3 as a fellow
9 papers
Grants
- 2019–2025
Understanding Interleukin-18 Mediated Susceptibility to Systemic Hyperinflammation
National Institute of Child Health and Human Development · R01
Contact PI · $1.7M · Children's Hosp of Philadelphia
- 2017–2019
Mechanisms of NLRC4 Inflammasome-Associated Hyperinflammation
National Institute of Allergy and Infectious Diseases · K22
Contact PI · $270K · University of Pittsburgh at Pittsburgh
- 2012–2013
Mechanisms by Which IL-10 Limits Toll-Like Receptor 9 Mediated Macrophage Activat
National Institute of Allergy and Infectious Diseases · F32
Contact PI · $59.4K · Children's Hosp of Philadelphia
Inflammatory Consequences of NLRC4 Dysregulation
National Institute of Arthritis and Musculoskeletal and Skin Diseases · ZIA
Contact PI · $1.3M · National Institute of Arthritis and Musculoskeletal and Skin Diseases
Clinical trials
- 2015–2028
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sub-investigator · Recruiting
Duke University